VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera to Report Second Quarter 2026 Fina

Does AbCellera Biologics Inc. (ABCL) have what it takes to be a top stock pick for momentum investor

Benchmark analyst Robert Wasserman upgrades AbCellera Biologics (NASDAQ:ABCL) from Hold to Buy an

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Appoints Dr. Lynn Seely to its Boa

Here is how AbCellera Biologics Inc. (ABCL) and Agilon Health (AGL) have performed compared to their

ABCELLERA BIOLG (ABCL) was a big mover last session on higher-than-average trading volume. The lates

Jazz Pharmaceuticals teams up with AbCellera to discover and develop T-cell-engaging antibodies for

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) announced on Wednesday a collaboration with AbCellera Biologi

Jazz Pharmaceuticals teams with AbCellera on cancer therapies as analysts maintain positive targets

Here is how AbCellera Biologics Inc. (ABCL) and Agilon Health (AGL) have performed compared to their

Jazz Pharmaceuticals has signed a research collaboration and licensing agreement with Canada's AbCel

The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in po

The collaboration includes $56 million in upfront payments to AbCellera and up to $792 million in po

DUBLIN & VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--Jazz Pharmaceuticals and AbCellera

AbCellera, an antibody platform behind two authorized COVID-19 therapies, has rebuilt itself into a

AbCellera Biologics Inc. remains rated Hold, with valuation concerns outweighing near-term pipeline

The average of price targets set by Wall Street analysts indicates a potential upside of 85.6% in AB

AbCellera Biologics Inc. (ABCL) Presents at Jefferies Global Healthcare Conference 2026 Transcript

[url="]AbCellera[/url] (Nasdaq: ABCL) today announced the appointment of Victor Sandor, M.D.C.M, to

VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera Appoints Dr. Victor Sandor to its

AbCellera Biologics NASDAQ: ABCL is emphasizing its transition from a partner-based antibody discove

Here is how AbCellera Biologics Inc. (ABCL) and C4 Therapeutics, Inc. (CCCC) have performed compared

From a technical perspective, AbCellera Biologics Inc. (ABCL) is looking like an interesting pick, a

AbCellera Biologics (NASDAQ:ABCL) reported quarterly losses of $(0.14) per share which beat the anal

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  During Thursday's session, 406 companies made new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f

  Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report

  Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report